Literature DB >> 10760367

Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers.

L Lacinová1, N Klugbauer, F Hofmann.   

Abstract

The pharmacological properties of the expressed murine T-type alpha(1G) channel were characterized using the whole cell patch clamp configuration. Ba(2+) or Ca(2+) were used as charge carriers. Both I(Ba) and I(Ca) were blocked by Ni(2+) and Cd(2+) with IC(50) values of 0.47+/-0.04 and 1.13+/-0.06 mM (Ni(2+)) and 162+/-13 and 658+/-23 microM (Cd(2+)), respectively. Ni(2+), but not Cd(2+), modified the gating of channel activation. Ni(2+) consistently accelerated channel deactivation while Cd(2+) had a similar effect only on I(Ca). The alpha(1G) channel was potently blocked by mibefradil in a dose- and voltage-dependent manner. I(Ba) was moderately blocked by phenytoin (IC(50) 73.9+/-1.9 microM) and was resistant to the block by valproate. Also 3 mM ethosuximide blocked 20 and 35% of the I(Ba) at a HP of -100 and -60 mV, respectively, while 5 mM amiloride inhibited I(Ba) by 38% and significantly slowed current activation. The alpha(1G) channel was not affected by 10 microM tetrodotoxin. Both 1 microM (+)isradipine and 10 microM nifedipine inhibited 18 and 14% of I(Ba) amplitude at a HP of -100 mV, and 23% and 29% of I(Ba) amplitude at a HP of -60 mV, respectively. The alpha(1G) current was minimally activated by 1 microM Bay K 8644.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760367     DOI: 10.1016/s0028-3908(99)00202-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  21 in total

1.  Mg(2+) block unmasks Ca(2+)/Ba(2+) selectivity of alpha1G T-type calcium channels.

Authors:  J R Serrano; S R Dashti; E Perez-Reyes; S W Jones
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

Review 2.  Dendritic low-threshold Ca2+ channels in rat cerebellar Purkinje cells: possible physiological implications.

Authors:  Pauline Cavelier; Jean-Louis Bossu
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 3.  Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.

Authors:  Anne Marie R Yunker
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

4.  Recruitment of apical dendritic T-type Ca2+ channels by backpropagating spikes underlies de novo intrinsic bursting in hippocampal epileptogenesis.

Authors:  Yoel Yaari; Cuiyong Yue; Hailing Su
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

5.  Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.

Authors:  Chun-Hwei Tai; Ya-Chin Yang; Ming-Kai Pan; Chen-Syuan Huang; Chung-Chin Kuo
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

6.  Ni2+ block of CaV3.1 (alpha1G) T-type calcium channels.

Authors:  Carlos A Obejero-Paz; I Patrick Gray; Stephen W Jones
Journal:  J Gen Physiol       Date:  2008-08       Impact factor: 4.086

7.  Iberiotoxin-sensitive and -insensitive BK currents in Purkinje neuron somata.

Authors:  Mark D Benton; Amanda H Lewis; Jason S Bant; Indira M Raman
Journal:  J Neurophysiol       Date:  2013-02-27       Impact factor: 2.714

Review 8.  T-type channels in the sino-atrial and atrioventricular pacemaker mechanism.

Authors:  Pietro Mesirca; Angelo G Torrente; Matteo E Mangoni
Journal:  Pflugers Arch       Date:  2014-02-27       Impact factor: 3.657

9.  Insulin-like growth factors (IGF) I and II utilize different calcium signaling pathways in a primary human parathyroid cell culture model.

Authors:  C K M Wong; T Lai; J M P Holly; M H Wheeler; C E H Stewart; J R Farndon
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

10.  Tetrodotoxin-sensitive Ca2+ Currents, but No T-type Currents in Normal, Hypertrophied, and Failing Mouse Cardiomyocytes.

Authors:  Ilona Bodi; Hiroyuki Nakayama; Arnold Schwartz
Journal:  J Cardiovasc Pharmacol       Date:  2016-12       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.